This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Lenders

1

BDCs

1

Facilities

2

Principal, latest

$25.0Mpieces as filed; a lower bound

Fair value, latest

$25.3M

Mark ratio

104%fair value over cost, latest

Next maturity

Sep 28, 2028

First on a schedule

Dec 31, 2025

Last on a schedule

Jun 30, 2026

• Occurred

  Mar 31, 2026
  Coupon changed

  Shield Therapeutics PLC term loan: spread moved from 9.25% to 8.75%

  BDC schedule of investments
  $2.0M
• Occurred

  Mar 31, 2026
  Spread decreased

  Runway Growth Finance Corp.: spread decreased in Shield Therapeutics PLC (9.25% to 8.75%)

  BDC schedule of investmentsobserved 4 months ago
  0.0875 usd
• Occurred

  Dec 31, 2025
  Borrower first appears on a BDC schedule

  Shield Therapeutics PLC first appears in a BDC schedule (1 lender)

  Runway Growth Finance Corp.BDC schedule of investmentsobserved 4 months ago
  $4.0M

Graph

Private Credit

Canonical id

dfx:pc:063a4d02-2d97-312a-a4b6-a4751f9aed85

First observed

Dec 31, 2025

Last observed

Jun 30, 2026 2 months ago

Resolution

Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.